Versameb Announces FDA Clearance of IND Application for VMB-100 in the Treatment of Stress Urinary Incontinence
Versameb AG (“Versameb”), a pre-clinical stage company focused…
IO Biotech Appoints Helen Collins, MD, to its Board of Directors
NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq:…
Mission Therapeutics announces publication in Nature Communications outlining potential of experimental drug MTX325 as a disease-modifying therapy for Parkinson’s Disease
International research collaboration between Harvard Medical…
Oxolife Appoints International Fertility Experts to its Scientific Advisory Board
Leading experts in fertility and human reproduction with…
Pharmaceutical distributor Mawdsleys unveils its expanded third-party logistics (3PL) warehouse in Doncaster – bigger and greener than before
Rt Hon Ed Miliband, Labour MP for Doncaster North and Shadow…
IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma
Trial expected to reach the primary endpoint of progression…
Poolbeg Pharma plc – Key Senior Members of Former Amryt Pharma Leadership Team join Poolbeg Pharma
Poolbeg team boosted by highly experienced executives with track…
Lytix Biopharma presents third quarter 2023 results
Oslo, 09 November 2023. Lytix Biopharma AS (“Lytix”) (Euronext…
IO Biotech Announces Participation in Upcoming Investor Conferences
NEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq:…
Lytix Biopharma presenting at major investor conferences in London and Stockholm in November
Oslo, 8 November 2023. Lytix Biopharma AS (“Lytix”) (Euronext…
Vicore to Present at the Stifel 2023 Healthcare Conference
Stockholm, November 7, 2023 – Vicore Pharma Holding AB…
Futura expands partnership with M8 Pharmaceuticals for remainder of Central and South American region
Futura Medical plc (AIM: FUM) ("Futura" or the "Company"), the…
Futura Medical – Eroxon Awarded “New Product of the Year, Healthcare” by Boots
Futura Medical plc (AIM: FUM) ("Futura" or the "Company"), the…
iOnctura to Present Research on Roginolisib and IOA-359 at ASH
Three abstracts accepted by ASH with two poster presentations
Geneva,…
Poolbeg Pharma plc – POLB 001 Data to be Presented at American Society of Hematology Annual Meeting
Potential to address cancer treatment related Cytokine Release…
Vicore Pharma: Interim report July-September 2023
Stockholm, November 2, 2023 – Vicore Pharma Holding AB (STO:…
Mission Therapeutics to Present Abstract at American Society of Nephrology (ASN) Kidney Week 2023
CAMBRIDGE, UK, 2 November 2023 – Mission Therapeutics (“Mission”),…
IO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
Non-clinical data demonstrate clear impact of immune modulating…
We’d love to hear from you.
For more information about Optimum Strategic Communications, please get in touch.
We are specialists with an indepth understanding of how to communicate complex science to investors and corporate stakeholders. We help companies on their journey as they grow and have been trusted by hundreds of clients from around the world, both public and private, large and small.
Locations
- London
- Amsterdam
- Stockholm
- Zurich
- New York